BIOPOLE SELAS

What BIOPOLE SELAS does

BIOPOLE SELAS is a private French medical biology laboratory network founded in 1977 and described as owned and directed exclusively by independent biologists. It operates 17 laboratory sites across Pyrénées-Atlantiques and Sud-Landes, with its headquarters at Pau Norman Prince, and serves individual patients, prescribing physicians, independent nurses, pharmacies, and EHPADs. Routine samples are processed through internal technical platforms at Orthez and Saint-Pierre-du-Mont, often enabling same-day results, while specialized tests are subcontracted to Eurofins-Biomnis.

Revenue is generated primarily from pay-as-you-go biological analyses reimbursed through France's social security system and supplementary insurers under generalized third-party payment, supplemented by direct patient payment for non-reimbursable tests. Its go-to-market combines direct walk-in access, physician and institutional referrals, home draws coordinated with independent nurses, and pharmacy-distributed sampling kits. Results are delivered through MesAnalyses.fr and secure healthcare-professional channels including MsSanté, Apicrypt, Bioserveur, and HPRIMNET; no revenue, patient-volume, or contract-value data is disclosed.

Name

BIOPOLE SELAS

Legal name

BIOPOLE SELAS

Website

https://laboratoirebiopole.com

Company type

Private

Founded year

1977

Operating status

Operating

Headcount range

11–50 employees

Short description

BIOPOLE SELAS operates a regional network of 17 medical biology laboratories serving patients, prescribing physicians, nurses, pharmacies, and elder-care facilities through walk-in sites, home collection, reimbursed testing, and secure result delivery.

Ownership category

akta.pro rank

Product category

Medical Laboratory Services

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Clinical Chemistry & Immunoassay Laboratories (HLAFAMAB)

akta.pro secondary industry

Reference & Esoteric Testing Laboratories (HLAFAMAJ)

Keywords

• Medical biology services
• Clinical laboratory analysis
• Blood testing services
• Biological diagnostics
• Pathology screening

Headquarters

HQ city

pau, Nouvelle-Aquitaine

HQ country

France

HQ region

Europe

Offices16 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations

Revenue model

1. Medical Biology Analysis Services: Core revenue from performing biological medical analyses. Reimbursed by French social security (Sécurité Sociale) and supplementary health insurance (mutuelles) through tiers payant system for covered examinations. Patients pay out-of-pocket for non-reimbursable analyses (hors nomenclature) such as blood type determination when not prescribed in pregnancy context.
2. Non-Reimbursable Analyses: Direct patient payment for analyses outside the official nomenclature (hors nomenclature), which may occasionally be covered by supplementary insurance.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

BIOPOLE SELAS operates a network of 17 medical biology laboratories providing routine blood tests, specialized biological analyses, and screening services (ISTs, cancer, diabetes, cholesterol, kidney disease) to individual patients in southwestern France. Two central technical platforms (Orthez and Saint-Pierre-du-Mont) perform routine analyses in-house for same-day results, while specialized tests are subcontracted to Eurofins-Biomnis. Services are delivered via walk-in sites, home collections through independent nurses, and a secure online results portal.

Product overview

BIOPOLE SELAS is a network of 17 independent medical biology laboratories in the Pyrénées-Atlantiques and Landes regions of France, owned and directed exclusively by independent biologists. The company operates two central technical platforms (in Orthez and Saint-Pierre-du-Mont) that perform routine analyses internally for same-day results. The core offering includes medical biology and analysis services (blood tests, specialized screenings), supplemented by home blood draw services coordinated with independent nurses, specialized analyses subcontracted to Eurofins-Biomnis, COVID-19 serological testing, and third-party billing services. Patients access results through the MesAnalyses.fr secure portal, while healthcare professionals receive results via MsSanté, Apicrypt, Bioserveur, or HPRIMNET secure platforms. The laboratory also provides a digital sampling manual with sample collection kits available at sites and pharmacies.

Differentiator

Problem solved

Functional benefit

Products and services

• Medical Biology and Analysis Services

Named customers5 records

Segments5 records

Ideal customer profiles2 records

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

Feature3 records

Partnerships

Four partnerships are on record, tiered core.

• Eurofins-BiomniscoreTechnology or IntegrationSubcontracting partnership for specialized biological analyses. Eurofins-Biomnis performs specialized biology tests that BIOPOLE cannot conduct internally. Data transmitted to BIOPOLE for consolidation with in-house results.
• MsSantécoreTechnology or IntegrationSecure health messaging platform for healthcare professionals to receive patient results electronically.
• BioserveurcoreTechnology or IntegrationSecure results server platform enabling healthcare professionals to receive patient test results without requiring integration software.
• ApicryptcoreTechnology or IntegrationEncrypted messaging service for secure transmission of patient results to prescribing physicians.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Inovie: Inovie is one of France's largest independent medical biology laboratory networks, structured around regional centers and patient-facing sites. Directly comparable to BIOPOLE because it operates a multi-site clinical lab model serving French patients under the NABM reimbursement framework with comparable walk-in and prescriber-driven demand.
• Biogroup-LCD: Biogroup-LCD is a major French independent medical biology laboratory network operating numerous patient-facing sites across France. Comparable to BIOPOLE because it provides the same clinical diagnostic testing services under NABM, though at much larger national scale and as one of the leading consolidators in the French market.
• Biomnis/EYLIA Group: EYLIA (formerly Eylia Group) is a French group of independent medical biology laboratories operating across multiple regions. Comparable to BIOPOLE because it operates multi-site clinical labs with the same independent-biologist ownership model and NABM reimbursement, representing a similar tier of French regional laboratory consolidator.

Broad incumbents

• Eurofins-Biomnis: Eurofins-Biomnis is the French specialty reference laboratory arm of Eurofins, performing advanced and esoteric testing for hospitals, clinicians, and other labs. Comparable to BIOPOLE because it operates clinical diagnostic laboratory services under French regulation, though it is also BIOPOLE's subcontracting partner and operates at much larger scale with national reach.
• Cerba HealthCare: Cerba HealthCare is a leading French and European clinical diagnostics laboratory network offering routine and specialty testing. Comparable to BIOPOLE because it operates medical biology services across multiple sites serving similar patient and prescriber populations, though at significantly larger scale and broader geographic reach.
• Synlab: Synlab is one of Europe's largest medical diagnostics services providers, operating clinical laboratories across multiple countries including France. Comparable to BIOPOLE because it provides clinical biology analysis services to patients and prescribers, though at substantially larger scale and broader geographic footprint.
• Unilabs: Unilabs is a European clinical diagnostics and laboratory services group operating across multiple countries with significant presence in France. Comparable to BIOPOLE because it provides medical biology and diagnostic testing to patients and healthcare professionals, but at much larger scale and international geographic scope.

Regional players

• Labosud (Synlab Provence): Labosud is an independent medical biology laboratory network operating in the Occitanie region of southern France. Comparable to BIOPOLE as a regional multi-site clinical lab serving patients under NABM reimbursement with similar walk-in and prescriber-driven demand, though operating in a different southwestern French geography.
• Oriade (formerly Novabio): Oriade is a French independent medical biology laboratory network concentrated in the Rhône-Alpes/Auvergne region. Comparable to BIOPOLE as a regional multi-site clinical lab operator serving patients under the same NABM framework, though it competes in a different French region rather than directly in Pyrénées-Atlantiques.
• Laborizon (former LBI): Laborizon (formerly Les Biologistes Indépendants) is a French independent medical biology laboratory network operating across multiple regions. Comparable to BIOPOLE because it operates multi-site clinical labs serving patients under the same French regulatory and reimbursement framework, with similar independent-biologist ownership heritage.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/biopole-selas

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BIOPOLE SELAS